Harbor Advisory Corp’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Harbor Advisory Corp's PFE Position: Q1 2026 in Review
Harbor Advisory Corp reduced its Pfizer (PFE) stake by 2% in Q1 2026, selling an estimated $98.5K and leaving 178,658 shares worth $5.02M. The position accounts for 1.51% of the portfolio, ranked #27.
Harbor Advisory Corp first reported a position in PFE in Q2 2021 and has held it in 20 quarters since. The position peaked at $5.3M in Q4 2022. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Harbor Advisory Corp held 178,658 shares of Pfizer worth $5.02M as of Q1 2026.
- Harbor Advisory Corp sold 3,699 Pfizer shares in Q1 2026, an estimated $98.5K.
- Pfizer made up 1.51% of Harbor Advisory Corp's portfolio in Q1 2026, its #27 holding.
- Harbor Advisory Corp first reported a position in Pfizer in Q2 2021 and has held it in 20 quarters since.
- Harbor Advisory Corp's Pfizer position peaked at $5.3M in Q4 2022.
- 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Harbor Advisory Corp's 13F filing for Q1 2026, filed 7 May 2026.